Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte®
PRESS RELEASES

HOME | NEWS / EVENTS | Press Releases

LABCYTE PRESS RELEASES

LABCYTE
PRESS RELEASES

DEC 17, 2013
Labcyte Commends Early Success of Collaborator, The Institute for Molecular Medicine Finland, for Personalized Leukemia Treatment Method

Just eight months after announcing a collaboration between Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM), the partnership has already led to a groundbreaking method for personalized treatment of patients with adult acute myeloid leukemia (AML).

DEC 04, 2013
Labcyte CEO Mark Fischer-Colbrie and CTO, Co-Founder Rich Ellson Named National EY Entrepreneur Of The Year™ 2013 Life Sciences Finalists

Novel technology enables major advancements in Life Sciences

NOV 20, 2013
National Cancer Institute Awards Labcyte $1 Million for Novel High-Throughput Cancer Biomarker Detection

Labcyte Inc., the acoustic dispensing company, has been awarded $1 million to create an innovative process to detect cancer-related proteins in samples, with initial work in breast cancer detection. The unsurpassed precision and accuracy of Labcyte acoustic liquid handling enables biomarker detection by measuring multiple proteins with a MALDI mass spectrometer. Recent work with the Canary Ce...

SEP 25, 2013
Labcyte Announces Collaboration with AstraZeneca to Develop Acoustic Sample Handling for Mass Spectrometry to Advance Drug Discovery

Labcyte Inc. today announced a collaboration with AstraZeneca to use acoustic dispensing combined with mass spectrometry to greatly advance drug discovery applications. Labcyte, who developed and commercialized acoustic liquid handling, recently developed techniques for the direct loading of samples into mass spectrometers. This capability creates the potential for high throughput, low cost, l...

JUL 24, 2013
Ernst & Young announces Labcyte Inc. CEO and President Mark Fischer-Colbrie and Co-Founder Rich Ellson as the Entrepreneur Of The Year® 2013 Award winner in Northern California

Ernst & Young LLP announced that Mark Fischer-Colbrie, CEO and President, and Rich Ellson, Co-Founder of Labcyte Inc., received the Ernst & Young Entrepreneur Of The Year® 2013 Award in the Life Sciences category in Northern California. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and perso...

MAY 02, 2013
Moving Liquids with Sound Using Labcyte Technology Finds Drug Candidates that Traditional Lab Techniques Miss

How do researchers know whether new molecules will have a positive or negative effect? How much does the technique for moving a liquid affect the results? What about testing compounds for their environmental or health impacts: Is one liquid handling process better than another when it comes to accuracy of the data? A paper published by the journal PLOS ONE, May 1, 2013, demonstrates that the...

JAN 14, 2013
Labcyte Announces the Launch of Echo 525 Liquid Handler: The First-Ever Large-Volume Acoustic Liquid Handler

Labcyte Inc., who is revolutionizing liquid handling with acoustic dispensing, today announced the latest addition to the Echo® liquid handler product family at the annual Society for Laboratory Automation and Screening conference. This innovative product expands Labcyte’s acoustic dispensing range by utilizing a larger droplet volume to enable more rapid liquid transfers in the microliter rang...

JAN 09, 2013
A Sound Combination for Superior Miniaturized Assay Preparation

Leading sample management software provider, Titian Software, and Labcyte Inc., have announced a smart integration of the Mosaic™ sample management suite with the Access™ workstation and POD™ automation platform – two Labcyte automation systems incorporating their revolutionary Echo® liquid handler. The combination of Mosaic’s powerful software and flexible integration modules, coupled with the...

JAN 08, 2013
Labcyte Inc. Closes $5.3 Million Financing

Labcyte Inc., a privately-held company advancing acoustic liquid handling, today announced it has closed a Series D financing led by the healthymagination fund, a part of GE Ventures. The $5.3 million round also included current Labcyte investors: Abingworth, Alloy Ventures, Cross Atlantic Partners, Delphi Ventures, H&Q Healthcare Investors (NYSE:HQH) and H&Q Life Sciences Investors (NYSE:HQL).

JAN 07, 2013
Labcyte and FIMM Announce a Collaboration Enabling “Real-Time” Science to Advance Personalized Medicine in Cancer Treatments

Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM) are collaborating to further the development of personalized medicine in cancer treatment. Labcyte acoustic liquid handling technology has already revolutionized small-molecule research. Now, FIMM, a European leader in advanced research for new cancer therapies, will apply the technology extensively in its personalized medicin...




MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP